JP2023513190A5 - - Google Patents
Info
- Publication number
- JP2023513190A5 JP2023513190A5 JP2022547889A JP2022547889A JP2023513190A5 JP 2023513190 A5 JP2023513190 A5 JP 2023513190A5 JP 2022547889 A JP2022547889 A JP 2022547889A JP 2022547889 A JP2022547889 A JP 2022547889A JP 2023513190 A5 JP2023513190 A5 JP 2023513190A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- vitamin
- composition according
- item
- poly
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062971775P | 2020-02-07 | 2020-02-07 | |
| US62/971,775 | 2020-02-07 | ||
| US202062989489P | 2020-03-13 | 2020-03-13 | |
| US62/989,489 | 2020-03-13 | ||
| US202063047151P | 2020-07-01 | 2020-07-01 | |
| US63/047,151 | 2020-07-01 | ||
| PCT/IB2021/050976 WO2021156833A1 (en) | 2020-02-07 | 2021-02-06 | Use of mirna-485 inhibitors for treating tauopathy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023513190A JP2023513190A (ja) | 2023-03-30 |
| JP2023513190A5 true JP2023513190A5 (https=) | 2024-02-14 |
Family
ID=77200812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022547889A Pending JP2023513190A (ja) | 2020-02-07 | 2021-02-06 | タウオパチーを治療するためのｍｉｒｎａ－４８５阻害剤の使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230099372A1 (https=) |
| EP (1) | EP4100065A4 (https=) |
| JP (1) | JP2023513190A (https=) |
| KR (1) | KR20220154106A (https=) |
| CN (1) | CN115461085A (https=) |
| AU (1) | AU2021215408A1 (https=) |
| CA (1) | CA3166604A1 (https=) |
| MX (1) | MX2022009447A (https=) |
| WO (1) | WO2021156833A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2021246024A1 (en) * | 2020-03-30 | 2022-10-27 | Alnylam Pharmaceuticals, Inc. | Microtubule associated protein Tau (MAPT) iRNA agent compositions and methods of use thereof |
| AU2021302972A1 (en) * | 2020-07-01 | 2023-02-09 | Biorchestra Co., Ltd. | miRNA-485 inhibitor for huntington's disease |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9951330B2 (en) * | 2013-07-11 | 2018-04-24 | The Trustees Of Columbia University In The City Of New York | Micrornas that silence tau expression |
| WO2018139759A1 (ko) * | 2017-01-26 | 2018-08-02 | 주식회사 바이오오케스트라 | 마이크로 rna를 이용한 알츠하이머병 진단방법 |
| WO2018139819A1 (ko) * | 2017-01-26 | 2018-08-02 | 주식회사 바이오오케스트라 | 마이크로 rna를 이용한 뇌 질환 예방 또는 치료 용도 |
| CN107287319B (zh) * | 2017-07-13 | 2021-07-02 | 青岛大学 | miRNA-485-5p核苷酸类似物及其反义核苷酸的应用和应用其的产品 |
| JPWO2019240223A1 (ja) * | 2018-06-13 | 2021-07-01 | 公益財団法人川崎市産業振興財団 | 数平均分子量が３ｋＤａ〜１０ｋＤａであるＰＥＧブロックとカチオン性ポリマーとのブロックコポリマーと、アンチセンスオリゴヌクレオチドとを含む、ポリイオンコンプレックスミセル |
| US10844380B1 (en) * | 2019-06-17 | 2020-11-24 | Biorchestra Co., Ltd. | Uses for prevention or treatment of brain diseases using microrna |
| EP3983549A4 (en) * | 2019-06-17 | 2023-06-28 | Biorchestra Co., Ltd. | Compositions and methods for preparing an alzheimer's disease animal model using microrna |
| WO2020261227A1 (en) * | 2019-06-26 | 2020-12-30 | Biorchestra Co., Ltd. | Micellar nanoparticles and uses thereof |
-
2021
- 2021-02-06 US US17/760,345 patent/US20230099372A1/en active Pending
- 2021-02-06 AU AU2021215408A patent/AU2021215408A1/en active Pending
- 2021-02-06 MX MX2022009447A patent/MX2022009447A/es unknown
- 2021-02-06 WO PCT/IB2021/050976 patent/WO2021156833A1/en not_active Ceased
- 2021-02-06 CN CN202180026416.9A patent/CN115461085A/zh active Pending
- 2021-02-06 CA CA3166604A patent/CA3166604A1/en active Pending
- 2021-02-06 KR KR1020227030527A patent/KR20220154106A/ko active Pending
- 2021-02-06 EP EP21750389.5A patent/EP4100065A4/en not_active Withdrawn
- 2021-02-06 JP JP2022547889A patent/JP2023513190A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Qi et al. | PEG-conjugated PAMAM dendrimers mediate efficient intramuscular gene expression | |
| Wiradharma et al. | Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect | |
| Kaur et al. | Modified mRNA as a therapeutic tool for the heart | |
| JP2022538868A5 (https=) | ||
| JPH11500431A (ja) | 核酸を含む組成物、その製造及び使用 | |
| KR20000023602A (ko) | 유전자 전달하는데 이용되는 양이온 고분자 및 리포프로테인을 포함하는 시스템 | |
| JP2010094128A (ja) | 核酸様化合物の送達 | |
| WO2019077149A1 (en) | USE OF SYNCYTINE FOR TARGETING DRUG AND GENE ADMINISTRATION TO REGENERATE MUSCLE TISSUE | |
| JP2023513190A5 (https=) | ||
| He et al. | p53 mediated apoptosis by reduction sensitive shielding ternary complexes based on disulfide linked PEI ternary complexes | |
| Fang et al. | A cancer cell membrane coated nanoparticles-based gene delivery system for enhancing cancer therapy | |
| Lin et al. | Sterically polymer-based liposomal complexes with dual-shell structure for enhancing the siRNA delivery | |
| JP2023513188A5 (https=) | ||
| JP2023532536A5 (https=) | ||
| Pan et al. | In vitro gene transfection in human glioma cells using a novel and less cytotoxic artificial lipoprotein delivery system | |
| JP2023513189A5 (https=) | ||
| JPWO2011025036A1 (ja) | 粒子組成物及びこれを有する医薬組成物 | |
| IL316806A (en) | Compositions and methods for treating monogenic neurodevelopmental disorder | |
| JP2024501437A5 (https=) | ||
| CA2278665A1 (fr) | Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees | |
| US12582669B2 (en) | Composition controlling pharmacokinetics in the body | |
| JP2024503302A5 (https=) | ||
| Lessl et al. | mCherry on Top: A Positive Read-Out Cellular Platform for Screening DMD Exon Skipping Xenopeptide–PMO Conjugates | |
| Verma et al. | < p style= | |
| CN113660938A (zh) | 核酸递送复合物 |